Onasemnogene‐abeparvovec administration to premature infants with spinal muscular atrophy

Documenti analoghi

• Preemptive dual therapy for children at risk for infantile‐onset spinal muscular atrophy
  di: Susan E. Matesanz, et al.
  Pubblicazione: (2024)
• Early spinal muscular atrophy treatment following newborn screening: A 20‐month review of the first Italian regional experience
  di: Delia Gagliardi, et al.
  Pubblicazione: (2024)
• Cortical atrophy patterns in myelin oligodendrocyte glycoprotein antibody‐associated disease
  di: Ruth Schneider, et al.
  Pubblicazione: (2024)
• Ethnoracial disparities in gray matter atrophy are mediated by structural disconnectivity in multiple sclerosis
  di: Ahmed Bayoumi, et al.
  Pubblicazione: (2025)
• Spatiotemporal spinal cord stimulation with real‐time triggering exoskeleton restores walking capability: a case report
  di: Penghao Liu, et al.
  Pubblicazione: (2024)